With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

Cystic Fibrosis is a rare autosomal recessive disease that causes sticky mucus to build up in the lungs, affecting numerous ...

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Most children with CF treated at a San Francisco CF clinic did not receive CF liver disease screening in accordance with current guidelines.

North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...

Researchers recently discovered that, in pulmonary diseases, M. abscessus suppresses immune responses during coinfection with ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK ® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic ...

Affordable access to life-changing treatment for cystic fibrosis will be expanded to more Australians with a change to the ...

A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...

Kirstin was born with a life limiting lung condition and would have died if it wasn't for an incredible donor who saved her ...